Related references
Note: Only part of the references are listed.AN ENVIRONMENTALLY BENIGN APPROACH FOR RAPID ANALYSIS OF INDOMETHACIN USING A STABILITY-INDICATING RP-HPLC METHOD
Nazrul Haq et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2014)
Improved stability and tumor targeting of 5-fluorouracil by conjugation with hyaluronan
Zhikui Dong et al.
JOURNAL OF APPLIED POLYMER SCIENCE (2013)
A validated, rapid UPLC-MS/MS method for simultaneous ivabradine, reboxetine, and metoprolol analysis in human plasma and its application to clinical trial samples
Alexander A. Zoerner et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Driving Under the Influence of Cannabis: Pitfalls, Validation, and Quality Control of a UPLC-MS/MS Method for the Quantification of Tetrahydrocannabinol in Oral Fluid Collected With StatSure, Quantisal, or Certus Collector
Sarah M. R. Wille et al.
THERAPEUTIC DRUG MONITORING (2013)
A novel 5-fluorouracil prodrug using hydroxyethyl starch as a macromolecular carrier for sustained release
Qing Luo et al.
CARBOHYDRATE POLYMERS (2012)
Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, spice and stimulants in oral fluid
Sabina Strano-Rossi et al.
JOURNAL OF CHROMATOGRAPHY A (2012)
Ultra-performance Liquid Chromatography-High-definition Mass Spectrometry Analysis of Constituents in the Root of Radix Stemonae and those Absorbed in Blood after Oral Administration of the Extract of the Crude Drug
Wei Dong et al.
PHYTOCHEMICAL ANALYSIS (2012)
Selective bone targeting 5-fluorouracil prodrugs: Synthesis and preliminary biological evaluation
Liang Ouyang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Design and synthesis of a β-lactamase activated 5-fluorouracil prodrug
Ryan M. Phelan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A Stability-Indicating RP-HPLC Assay Method for 5-Fluorouracil
V. R. Sinha et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Validated High-Performance Liquid Chromatographic Technique for Determination of 5-Fluorouracil: Applications to Stability Studies and Simulated Colonic Media
Fars K. Alanazi et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2009)
Development of a sensitive and selective LC-MS/MS method for the determination of α-fluoro-β-alanine, 5-fluorouracil and capecitabine in human plasma
Hermes Licea-Perez et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Development and validation of the HPLC method for the analysis of trimetazidine hydrochloride in bulk drug and pharmaceutical dosage forms
M. A. Naushad et al.
JOURNAL OF ANALYTICAL CHEMISTRY (2008)
Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review
Georgios V. Koukourakis et al.
MOLECULES (2008)
Development and bioavailability assessment of ramipril nanoemulsion formulation
Sheikh Shafiq et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Ultra-performance liquid chromatography coupled to time of flight mass spectrometry (UPLC-TOF): A novel tool for multiresidue screening of veterinary drugs in urine
Anton Kaufmann et al.
ANALYTICA CHIMICA ACTA (2007)
High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma
OT Fahmy et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients
F Casale et al.
PHARMACOLOGICAL RESEARCH (2004)
Validated liquid chromatographic determination of 5-fluorouracil in human plasma
IA Alsarra et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Synthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates
TWB Cai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study
CA Presant et al.
INVESTIGATIONAL NEW DRUGS (2002)
Share Paper
